# Effectiveness of Two Aspirin Doses for Prevention of Hypertensive Disorders of Pregnancy: ASPIRIN TRIAL

> **NCT06468202** · PHASE4 · RECRUITING · sponsor: **Ohio State University** · enrollment: 10742 (estimated)

## Conditions studied

- Hypertensive Disorders of Pregnancy
- Preeclampsia
- Gestational Hypertension

## Interventions

- **DRUG:** Aspirin 81 mg
- **DRUG:** Aspirin 162 mg

## Key facts

- **NCT ID:** NCT06468202
- **Lead sponsor:** Ohio State University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-10-18
- **Primary completion:** 2029-01-01
- **Final completion:** 2030-02-01
- **Target enrollment:** 10742 (ESTIMATED)
- **Last updated:** 2026-05-04

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06468202

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06468202, "Effectiveness of Two Aspirin Doses for Prevention of Hypertensive Disorders of Pregnancy: ASPIRIN TRIAL". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06468202. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*